Portfolio company
Alector
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops therapies for neurodegenerative diseases using a blood-brain barrier delivery platform for patients with conditions including ALS and Parkinson’s.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Yumanity Therapeutics
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
Aliada Therapeutics
This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.
VectorY
This biotechnology company develops vectorized antibody therapies for patients with neurodegenerative and muscular disorders, including amyotrophic lateral sclerosis and Parkinson's disease.
Denali Therapeutics
This biopharmaceutical company develops medicines crossing the blood-brain barrier to treat patients with neurodegenerative diseases and lysosomal storage disorders.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.
Athira Pharma
This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.
QurAlis
This company develops precision medicines for patients with amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.
Neumora Therapeutics
This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.
